Clinical features of Chinese patients with Huntington's disease carrying CAG repeats beyond 60 within HTT gene

Clinical Genetics

Volumn 85, Issue 2, 2014, Pages 189-193

  Liu, Z J ^a,b   Sun, Y M ^a   Ni, W ^a,b   Dong, Y ^a   Shi, S S ^a   Wu, Z Y ^a  

^a FUDAN UNIVERSITY   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

CAG repeats beyond 60; HTT; Huntington's disease

Indexed keywords

HUNTINGTIN; HTT PROTEIN, HUMAN; NERVE PROTEIN;

AGED; ARTICLE; ATAXIA; BRADYKINESIA; BRAIN ATROPHY; CAG REPEAT; CASE REPORT; CHINESE; CHOREA; CLINICAL FEATURE; CLONUS; COGNITIVE DEFECT; DYSARTHRIA; DYSPHAGIA; DYSTONIA; EPILEPSY; FEMALE; GAIT DISORDER; GILLES DE LA TOURETTE SYNDROME; HUMAN; HUNTINGTON CHOREA; INTELLECTUAL IMPAIRMENT; KYPHOSIS; MALE; MEMORY DISORDER; MENTAL DISEASE; ONSET AGE; PRIORITY JOURNAL; SLURRED SPEECH; TENDON REFLEX; TIC; VERY ELDERLY; WALKING DIFFICULTY; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DNA SEQUENCE; GENETICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PEDIGREE; PHENOTYPE; TRINUCLEOTIDE REPEAT;

AGE OF ONSET; ASIAN CONTINENTAL ANCESTRY GROUP; CHILD; HUMANS; HUNTINGTON DISEASE; MAGNETIC RESONANCE IMAGING; NERVE TISSUE PROTEINS; PEDIGREE; PHENOTYPE; SEQUENCE ANALYSIS, DNA; TOMOGRAPHY, X-RAY COMPUTED; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84892485010     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12120     Document Type: Article

References (32)

1. Tabrizi SJ, Langbehn DR, Leavitt BR et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol 2009: 8 (9): 791-801.
2. Rubinsztein DC, Leggo J, Coles R et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 1996: 59 (1): 16-22.
3. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993: 72 (6): 971-983.
4. Andresen JM, Gayan J, Djousse L et al. The relationship between CAG repeat length and age of onset differs for Huntington's disease patients with juvenile onset or adult onset. Ann Hum Genet 2007: 71 (Pt 3): 295-301.
5. Duyao M, Ambrose C, Myers R et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet 1993: 4 (4): 387-392.
6. Squitieri F, Frati L, Ciarmiello A, Lastoria S, Quarrell O. Juvenile Huntington's disease: does a dosage-effect pathogenic mechanism differ from the classical adult disease? Mech Ageing Dev 2006: 127 (2): 208-212.
7. Squitieri F, Berardelli A, Nargi E et al. Atypical movement disorders in the early stages of Huntington's disease: clinical and genetic analysis. Clin Genet 2000: 58 (1): 50-56.
8. Cannella M, Gellera C, Maglione V et al. The gender effect in juvenile Huntington disease patients of Italian origin. Am J Med Genet B Neuropsychiatr Genet 2004: 125B (1): 92-98.
9. Rosenblatt A, Kumar BV, Mo A, Welsh CS, Margolis RL, Ross CA. Age, CAG repeat length, and clinical progression in Huntington's disease. Mov Disord 2012: 27 (2): 272-276.
10. Nance MA, Myers RH. Juvenile onset Huntington's disease - clinical and research perspectives. Ment Retard Dev Disabil Res Rev 2001: 7 (3): 153-157.
11. Losekoot M, van Belzen MJ, Seneca S, Bauer P, Stenhouse SA, Barton DE. EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease. Eur J Hum Genet 2012. DOI: 10.1038/ejhg.2012.200.
12. Ruocco HH, Lopes-Cendes I, Laurito TL, Li LM, Cendes F. Clinical presentation of juvenile Huntington disease. Arq Neuropsiquiatr 2006: 64 (1): 5-9.
13. Cloud LJ, Rosenblatt A, Margolis RL et al. Seizures in juvenile Huntington's disease: Frequency and characterization in a multicenter cohort. Mov Disord 2012: 27 (14): 1797-1800.
14. Ribai P, Nguyen K, Hahn-Barma V et al. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients. Arch Neurol 2007: 64 (6): 813-819.
15. Tang Y, Wang Y, Yang P et al. Intergeneration CAG expansion and contraction in a Chinese HD family. Am J Med Genet B Neuropsychiatr Genet 2006: 141B (3): 242-244.
16. Xing S, Chen L, Chen X, Pei Z, Zeng J, Li J. Excessive blinking as an initial manifestation of juvenile Huntington's disease. Neurol Sci 2008: 29 (4): 275-277.
17. Dong Y, Sun YM, Liu ZJ, Ni W, Shi SS, Wu ZY. Chinese patients with Huntington's disease initially presenting with spinocerebellar ataxia. Clin Genet 2012. DOI: 10.1111/j.1399-0004.2012.01927.x.
18. Quarrell O, O'Donovan KL, Bandmann O, Strong M. The prevalence of Juvenile Huntington's disease: a review of the literature and meta-analysis. PLoS Curr 2012. DOI: 10.1371/4f8606b742ef3.
19. Nance MA. Genetic testing of children at risk for Huntington's disease. US Huntington Disease Genetic Testing Group. Neurology 1997: 49 (4): 1048-1053.
20. Chuo YP, Hou PH, Chan CH, Lin CC, Liao YC. Juvenile Huntington's disease presenting as difficult-to-treat seizure and the first episode of psychosis. Gen Hosp Psychiatry 2012: 34 (9): 436-439.
21. Gonzalez-Alegre P, Afifi AK. Clinical characteristics of childhood-onset (juvenile) Huntington disease: report of 12 patients and review of the literature. J Child Neurol 2006: 21 (3): 223-229.
22. Rasmussen A, Macias R, Yescas P, Ochoa A, Davila G, Alonso E. Huntington disease in children: genotype-phenotype correlation. Neuropediatrics 2000: 31 (4): 190-194.
23. Sakazume S, Yoshinari S, Oguma E et al. A patient with early onset Huntington disease and severe cerebellar atrophy. Am J Med Genet A 2009: 149A (4): 598-601.
24. Yoon G, Kramer J, Zanko A et al. Speech and language delay are early manifestations of juvenile-onset Huntington disease. Neurology 2006: 67 (7): 1265-1267.
25. Waugh JL, Miller VS, Chudnow RS, Dowling MM. Juvenile Huntington disease exacerbated by methylphenidate: case report. J Child Neurol 2008: 23 (7): 807-809.
26. Nahhas FA, Garbern J, Krajewski KM, Roa BB, Feldman GL. Juvenile onset Huntington disease resulting from a very large maternal expansion. Am J Med Genet A 2005: 137A (3): 328-331.
27. Nicolas G, Devys D, Goldenberg A et al. Juvenile Huntington disease in an 18-month-old boy revealed by global developmental delay and reduced cerebellar volume. Am J Med Genet A 2011: 155A (4): 815-818.
28. Schapiro M, Cecil KM, Doescher J, Kiefer AM, Jones BV. MR imaging and spectroscopy in juvenile Huntington disease. Pediatr Radiol 2004: 34 (8): 640-643.
29. Gan SR, Shi SS, Wu JJ et al. High frequency of Machado-Joseph disease identified in southeastern Chinese kindreds with spinocerebellar ataxia. BMC Med Genet 2010: 11: 47.
30. Carvalho DR, La Rocque-Ferreira A, Rizzo IM, Imamura EU, Speck-Martins CE. Homozygosity enhances severity in spinocerebellar ataxia type 3. Pediatr Neurol 2008: 38 (4): 296-299.
31. Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 1996: 11 (2): 136-142.
32. Trouillas P, Takayanagi T, Hallett M et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 1997: 145 (2): 205-211.